SAFE vs convertible note, for an India-origin founder.

Convertible note: A debt instrument. Investor lends money to the company; the note bears interest (typically 2-8%); on a qualified future financing round, the note converts to preferred stock at a discount or at a capped valuation. Maturity date typically 18-24 months — if no qualifying round happens by maturity, the note either repays or converts at a specified fallback.

SAFE (Simple Agreement for Future Equity): Not debt. Not equity until conversion. Developed by Y Combinator in 2013 as a founder-friendly alternative to notes. No interest, no maturity date. Converts to preferred stock on a qualified financing event (and sometimes on a dissolution or liquidity event) at a discount or capped valuation.

Interest: Note has it (compounding typically 5-8% annually; the compounded principal converts). SAFE has none. For a 24-month note at 6% compounding, the investor's principal converts at ~113% of original investment. SAFE converts at 100%.

Maturity: Note has one — if no priced round by maturity, repayment or forced conversion at a default price. SAFE has none — it can sit indefinitely. In practice almost all SAFEs convert in a priced round within 12-24 months regardless.

Debt character: Note is debt until conversion, which has downstream implications: it sits on the balance sheet as a liability, it can trigger insolvency tests, and in bankruptcy it ranks ahead of equity. SAFE is neither debt nor equity — sits in a 'future equity' line item.

Dilution math on conversion: Pre-money vs post-money SAFEs matter. The 2018 YC post-money SAFE converts after the new money is included in the base, which allocates more dilution to the founder than a pre-money SAFE at the same cap would. Model carefully.

Legal cost: SAFE is a 5-page standardised form (YC free). Convertible note is 10-15 pages, often with investor-specific redlines. SAFE closes faster and cheaper.

For an Indian-resident founder of a Delaware C-Corp (post-flip) raising via SAFE or note from US investors, the instrument's conversion to preferred stock is a transaction between the Delaware company and the US investor — the Indian founder is not a party and has no personal Indian tax trigger at that point.

However, dilution effects on the founder's share count matter:

• At the next priced round, the SAFE / note converts into preferred stock, diluting the founder's percentage. This is a dilution event, not a taxable event for the founder.
• If the founder is also receiving fresh founder-equity grants or exercising stock options alongside the conversion, those grants/exercises are their own tax events.

Where Indian tax actually attaches:

• If the SAFE / note is being issued by an Indian company (not Delaware), compulsorily convertible debentures (CCDs) are the Indian equivalent — FDI route, FEMA pricing guidelines apply, Form FC-GPR on issue, Form FC-TRS if transferred.
• SAFEs in Indian company structure are regulatorily problematic — FEMA has not clearly recognised the SAFE as a permitted instrument. CCDs or convertible preference shares are the standard Indian alternatives.

US angel or seed VC into Delaware C-Corp: SAFE is the standard default in 2026. YC post-money SAFE form, standard valuation cap, standard discount. Closes in days.

Non-institutional investor who insists on debt-flavored instrument: Convertible note. Interest 4-6%, maturity 18-24 months, discount 15-20%, cap at a defensible number.

Indian angel into Indian company: CCD (compulsorily convertible debenture) under FEMA. Not SAFE. If you need SAFE-style simplicity, flip to Delaware first.

Series A term-sheet imminent: If a priced Series A is 60-90 days away, raise the gap money as a SAFE — it converts cleanly into the Series A preferred. Avoid issuing new SAFEs at a cap close to the expected Series A valuation (minimal discount means minimal upside for the SAFE investor; investor may push for note instead).